CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - UNAUDITED - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance - March 31, 2024 at Dec. 31, 2022	$ 87,482	$ 144,353	$ (633,726)	$ (401,891)
Beginning balance, shares at Dec. 31, 2022	87,482,208
Common Stock Issued for Accounts Payable and Accrued Expenses	$ 95,714	306,286		402,000
Common Stock Issued for Accounts Payable and Accrued Expenses, shares	95,714,286
Common Stock Issued to Prepay Director for Payment of Operating Expenses	$ 6,905	22,095		29,000
Common Stock Issued to Prepay Director for Payment of Operating Expenses, shares	6,904,761
Common Stock Issued for Board of Director & Consulting Services	$ 40,952	131,048		172,000
Common Stock Issued for Board of Director & Consulting Services, shares	40,952,381
Net Loss for the Period			(196,358)	(196,358)
Balance - June 30, 2024 at Mar. 31, 2023	$ 231,053	603,782	(830,084)	4,751
Ending balance, shares at Mar. 31, 2023	231,053,636
Capital Contributions - Directors		1,760		1,760
Net Loss for the Period			(10,298)	(10,298)
Balance - June 30, 2024 at Jun. 30, 2023	$ 231,053	605,542	(840,382)	(3,787)
Ending balance, shares at Jun. 30, 2023	231,053,636
Balance - March 31, 2024 at Dec. 31, 2023	$ 231,053	625,192	(866,037)	(9,792)
Beginning balance, shares at Dec. 31, 2023	231,053,636
Common Stock Sold	$ 5,833	344,167		350,000
Common Stock Sold, shares	5,833,333
Capital Contributions - Directors		700		700
Net Loss for the Period			(165,596)	(165,596)
Balance - June 30, 2024 at Mar. 31, 2024	$ 236,886	970,059	(1,031,633)	175,312
Ending balance, shares at Mar. 31, 2024	236,886,969
Common Stock Sold	$ 1,250	73,750		75,000
Common Stock Sold, shares	1,250,000
Net Loss for the Period			(92,999)	(92,999)
Balance - June 30, 2024 at Jun. 30, 2024	$ 238,136	$ 1,043,809	$ (1,124,632)	$ 157,313
Ending balance, shares at Jun. 30, 2024	238,136,969